193 related articles for article (PubMed ID: 16997912)
1. CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].
Wang MZ; Saulter JY; Usuki E; Cheung YL; Hall M; Bridges AS; Loewen G; Parkinson OT; Stephens CE; Allen JL; Zeldin DC; Boykin DW; Tidwell RR; Parkinson A; Paine MF; Hall JE
Drug Metab Dispos; 2006 Dec; 34(12):1985-94. PubMed ID: 16997912
[TBL] [Abstract][Full Text] [Related]
2. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
[TBL] [Abstract][Full Text] [Related]
3. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
[TBL] [Abstract][Full Text] [Related]
4. The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.
Michaels S; Wang MZ
Drug Metab Dispos; 2014 Aug; 42(8):1241-51. PubMed ID: 24816681
[TBL] [Abstract][Full Text] [Related]
5. Compartmental and enzyme kinetic modeling to elucidate the biotransformation pathway of a centrally acting antitrypanosomal prodrug.
Generaux CN; Ainslie GR; Bridges AS; Ismail MA; Boykin DW; Tidwell RR; Thakker DR; Paine MF
Drug Metab Dispos; 2013 Feb; 41(2):518-28. PubMed ID: 23223498
[TBL] [Abstract][Full Text] [Related]
6. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue.
Sturk LM; Brock JL; Bagnell CR; Hall JE; Tidwell RR
Acta Trop; 2004 Jul; 91(2):131-43. PubMed ID: 15234662
[TBL] [Abstract][Full Text] [Related]
7. Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry.
Zhou L; Thakker DR; Voyksner RD; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
J Mass Spectrom; 2004 Apr; 39(4):351-60. PubMed ID: 15103648
[TBL] [Abstract][Full Text] [Related]
8. A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat.
Yamaori S; Araki N; Shionoiri M; Ikehata K; Kamijo S; Ohmori S; Watanabe K
J Pharmacol Exp Ther; 2018 Sep; 366(3):446-457. PubMed ID: 29976573
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.
Zhou L; Voyksner RD; Thakker DR; Stephens CE; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
Rapid Commun Mass Spectrom; 2002; 16(11):1078-85. PubMed ID: 11992511
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
12. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.
Hashizume T; Imaoka S; Mise M; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
J Pharmacol Exp Ther; 2002 Jan; 300(1):298-304. PubMed ID: 11752129
[TBL] [Abstract][Full Text] [Related]
14. Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug.
Zhou L; Lee K; Thakker DR; Boykin DW; Tidwell RR; Hall JE
Pharm Res; 2002 Nov; 19(11):1689-95. PubMed ID: 12458675
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
16. CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis.
Jin Y; Zollinger M; Borell H; Zimmerlin A; Patten CJ
Drug Metab Dispos; 2011 Feb; 39(2):191-8. PubMed ID: 21045201
[TBL] [Abstract][Full Text] [Related]
17. Discovery of rubiarbonone C as a selective inhibitor of cytochrome P450 4F enzymes.
Choi YJ; Quan KT; Park I; Lee SJ; Kang KW; Na M; Kim SK
Arch Toxicol; 2018 Nov; 92(11):3325-3336. PubMed ID: 30259074
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
Casabar RC; Wallace AD; Hodgson E; Rose RL
Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
20. Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes.
Dalmadi B; Leibinger J; Szeberényi S; Borbás T; Farkas S; Szombathelyi Z; Tihanyi K
Drug Metab Dispos; 2003 May; 31(5):631-6. PubMed ID: 12695352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
